IR Head - HK Pre IPO Biotech

上海 全职 查看职位描述
We are seeking a Head of Investor Relations to lead the company's capital markets strategy and Hong Kong IPO process. Reporting directly to the CEO, this individual will play a critical role in positioning the business for its next phase of growth.
  • Clear HK IPO plan
  • Directly report to CEO

关于我们的客户

Our client is a PE-backed healthcare company with commercialized products and a strong growth trajectory. Following a significant acquisition and the successful advancement of its financing activities, the company is preparing for a Hong Kong IPO, with an expected filing in early 2027.

职责描述

  • Lead all investor relations activities and serve as the primary interface between the company and the investment community.
  • Develop and articulate a compelling equity story aligned with the company's growth strategy and value proposition.
  • Partner closely with the CEO, CFO, board members, sponsors, and external advisors on IPO preparation and execution.
  • Coordinate key workstreams related to the Hong Kong listing process, including investor messaging, roadshows, analyst engagements, and due diligence activities.
  • Manage relationships with institutional investors, analysts, investment banks, and other capital market participants.
  • Support fundraising initiatives and strategic financing activities prior to IPO.
  • Prepare investor presentations, shareholder communications, management briefing materials, and other capital markets content.
  • Monitor market trends, peer developments, and investor sentiment to provide strategic insights to senior management.
  • Build a investor relations framework to support the company through listing and beyond.



理想的求职者

  • Bachelor's degree or above in Finance, Economics, Business, Life Sciences, or a related discipline.
  • Proven Investor Relations experience within the pharmaceutical, biotechnology, medical device, or broader healthcare sector.
  • Strong understanding of Hong Kong capital markets and public market investor communications.
  • Experience engaging with buy-side institutions, sell-side analysts, and capital market stakeholders.
  • Demonstrated ability to work effectively with senior executives and external advisors.
  • Excellent communication, presentation, and stakeholder management skills.
  • Fluent in both Mandarin and English.
  • Prior participation in a full IPO cycle, particularly a Hong Kong listing, will be considered a strong advantage.
  • Experience within a fast-growth, PE-backed, or pre-IPO environment is highly desirable.

薪酬待遇

  • Direct exposure to the CEO and board-level decision-making.
  • Opportunity to lead the company's IPO journey from pre-listing preparation through execution.
  • Join a healthcare platform with strong commercial foundations and an expanding pipeline.
  • Play a critical role in important value-creation phases in the company's history.
  • Attractive compensation package, including long-term incentives and significant career development opportunities.
联系
Stella Mao
职位编号
JN-092026-7107674
联系电话
+8621 6026 8063

职位概要

职位类别
财务与会计
子类别
投资者关系
行业
医疗保健/制药
地区
上海
工作类型
全职
顾问名字
Stella Mao
顾问电话号码
+8621 6026 8063
职位编号
JN-092026-7107674

米高蒲志集团的多元与包容文化

在米高蒲志,我们不仅接受差异,更为之感到自豪。我们鼓励来自不同背景的求职者申请这个职位,并致力于建设包容、多样的工作场所,让所有员工都能绽放自我,成就精彩人生。如果您在招聘过程中需要任何支持或合理的调整,请告知我们。